Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$521M |
| 2 |
Becton Dickinson
BDX
|
+$411M |
| 3 |
GE Aerospace
GE
|
+$361M |
| 4 |
IBM
IBM
|
+$305M |
| 5 |
Philip Morris
PM
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$455M |
| 2 |
NetEase
NTES
|
+$451M |
| 3 |
Medtronic
MDT
|
+$398M |
| 4 |
NVIDIA
NVDA
|
+$348M |
| 5 |
Netflix
NFLX
|
+$332M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.95% |
| 2 | Technology | 14.39% |
| 3 | Financials | 10.63% |
| 4 | Industrials | 9.92% |
| 5 | Consumer Discretionary | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GCAP
2026
DELISTED
Gain Capital Holdings, Inc.
GCAP
| $3.52M | ﹤0.01% |
351,700
-177,000
| -33% | -$1.27M |
|
|
LBY
2027
DELISTED
Libbey, Inc.
LBY
| $3.51M | ﹤0.01% |
467,200
+23,107
| +5% | +$180K |
|
2028
Steris
STE
$23B
| $3.51M | ﹤0.01% |
40,100
-179,700
| -82% | -$16M |
|
2029
First Trust Senior Loan Fund ETF
FTSL
$2.33B
| $3.51M | ﹤0.01% |
+73,000
| New | +$3.52M |
|
|
ADAM
2030
Adamas Trust
ADAM
$907M
| $3.51M | ﹤0.01% |
142,075
+68,950
| +94% | +$1.73M |
|
2031
Southern First Bancshares
SFST
$607M
| $3.49M | ﹤0.01% |
84,700
+13,609
| +19% | +$541K |
|
2032
Novavax
NVAX
$1.34B
| $3.49M | ﹤0.01% |
140,778
+5,280
| +4% | +$129K |
|
2033
OneSpan
OSPN
$609M
| $3.48M | ﹤0.01% |
250,170
-214,100
| -46% | -$2.83M |
|
|
SFE
2034
DELISTED
Safeguard Scientifics, Inc.
SFE
| $3.46M | ﹤0.01% |
309,417
+92,300
| +43% | +$1.18M |
|
|
BWP
2035
DELISTED
Boardwalk Pipeline Partners
BWP
| $3.45M | ﹤0.01% |
266,900
-646,168
| -71% | -$9.13M |
|
2036
First Business Financial Services
FBIZ
$593M
| $3.44M | ﹤0.01% |
155,600
-10,900
| -7% | -$246K |
|
|
ALO
2037
DELISTED
Alio Gold Inc
ALO
| $3.44M | ﹤0.01% |
937,780
+254,930
| +37% | +$923K |
|
2038
BOK Financial
BOKF
$8.85B
| $3.44M | ﹤0.01% |
37,242
-9,200
| -20% | -$812K |
|
2039
Flexsteel Industries
FLXS
$301M
| $3.44M | ﹤0.01% |
73,500
+10,800
| +17% | +$529K |
|
|
CBK
2040
DELISTED
Christopher & Banks Corporation
CBK
| $3.42M | ﹤0.01% |
2,695,100
+94,900
| +4% | +$120K |
|
2041
Xencor
XNCR
$1.71B
| $3.42M | ﹤0.01% |
156,000
+56,400
| +57% | +$1.22M |
|
2042
Hilton Worldwide
HLT
$72.2B
| $3.4M | ﹤0.01% |
+42,600
| New | +$3.16M |
|
2043
ICL Group
ICL
$6.96B
| $3.4M | ﹤0.01% |
841,700
+379,800
| +82% | +$1.58M |
|
2044
Bankunited
BKU
$3.41B
| $3.4M | ﹤0.01% |
83,400
-289,400
| -78% | -$10.5M |
|
2045
UFP Industries
UFPI
$5.06B
| $3.39M | ﹤0.01% |
90,109
-126,500
| -58% | -$4.65M |
|
|
NXTM
2046
DELISTED
NxStage Medical Inc.
NXTM
| $3.39M | ﹤0.01% |
+139,900
| New | +$3.69M |
|
|
OIIM
2047
DELISTED
02Micro International
OIIM
| $3.38M | ﹤0.01% |
2,022,900
-20,083
| -1% | -$35.7K |
|
2048
TETRA Technologies
TTI
$1.25B
| $3.37M | ﹤0.01% |
788,300
+764,700
| +3,240% | +$2.64M |
|
2049
Ampco-Pittsburgh
AP
$190M
| $3.36M | ﹤0.01% |
271,200
+6,700
| +3% | +$101K |
|
|
CNSL
2050
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $3.36M | ﹤0.01% |
275,541
-186,976
| -40% | -$2.94M |
|
Similar funds
Jim Simons's Q4 2017 Portfolio in Review
As of Q4 2017, Jim Simons held 3,692 positions worth $90.7B, up 6.7% from $85B the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.
Jim Simons's Q4 2017 filing shows 521 new, 1,724 increased, 1,031 reduced and 386 closed positions. Its largest new stake was Alphabet (Google) Class C: 3,773,700 shares worth $197M. The largest sale was CR Bard Inc., an estimated $455M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 17% a quarter earlier, followed by Technology and Financials.
- Jim Simons's largest Q4 2017 buy was Alphabet (Google) Class C: 3,773,700 shares worth $197M.
- Jim Simons added most to ExxonMobil in Q4 2017, an estimated $521M increase.
- Jim Simons's biggest Q4 2017 reduction was NetEase, cutting an estimated $451M.
- Jim Simons fully exited CR Bard Inc. in Q4 2017, selling an estimated $455M.
- Jim Simons's ten largest holdings make up 8.4% of its $90.7B portfolio in Q4 2017.
- Jim Simons opened 521 new positions and closed 386 in Q4 2017.
- Jim Simons's portfolio value rose 6.7% quarter-over-quarter to $90.7B.
Based on Renaissance Technologies's 13F filing for Q4 2017, filed 13 Feb 2018.